A carregar...
Attitudes of Individuals with Gaucher Disease toward Substrate Reduction Therapies
Type 1 Gaucher disease (GD) is the most common lysosomal storage disorder. Previously, treatment for GD was limited to intravenous enzyme replacement therapies (ERTs). More recently, oral substrate reduction therapies (SRTs) were approved for treatment of GD. Although both therapies alleviate diseas...
Na minha lista:
| Publicado no: | J Genet Couns |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer US
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5794801/ https://ncbi.nlm.nih.gov/pubmed/28803392 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10897-017-0137-0 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|